News

  • Boosting innovation in the life sciences

    The IN2LifeSciences partnership presents its project video, explaining how IN2LS accelerates the achievement of SMEs in northwest Europe.
    Please feel free to share this animation with your business network.

    Enjoy watching!

    Vimeo: https://vimeo.com/108497273
    YouTube: http://youtu.be/iw9UleyOrxo

  • Revolutionary personalized therapy for liver cancer patients

    IN2LifeSciences helped Dutch research firm Quirem Medical work together with German regulatory consultants Capamed. The collaboration aims to help Quirem to obtain the required certification for software used in their revolutionary therapy for liver cancer. Due to the small number of companies active in the Radiotherapy field, specific regulatory compliances are needed to ensure treatments meet European specifications.

    Jan Sigger, Quirem CEO: “Through the collaboration of Quirem Medical and Capamed, a company with unique understanding of our situation, we’ll be able to offer physicians software to accurately identify, target and evaluate tumors both prior to and after treatment. This yields significant benefits for patients with liver cancer.

    IN2LifeSciences is a highly effective catalyst for companies in driving their innovations to the next level by extending their partner base.”

  • Enerban and Bakasable create user-friendly app to monitor health indicators

    Belgian SME Enerban develops a range of connected devices and services dedicated to 'health and care’, with a state−of−the−art cloud infrastructure giving users access from anywhere. Assisted by a virtual companion, Miiya, Enerban's users can effortlessly monitor a set of health indicators.

    Enerban first focused on carefully defining which kind of user experience they were looking for. That work allowed Bakasable (Pays de la Loire, France) to create an application architecture that catered to Enerban's specific needs. Finally, Bakasable produced the look and feel of the app, paying much attention to ergonomics and simplicity.

     

Pages